Trial intelligence / Profile preview

Simethicone in gynecological laparoscopy

NCT02984176Phase 4Completed

Sponsor
Woman's Health University Hospital
Start
Aug 2014
Primary completion
Jul 2015
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of simethicone in abdominal bloating and flatulence, sponsored by Woman's Health University Hospital. Primary endpoints: Overall exposure of the surgical field at 1 hour and Postoperative pain at 24 hours. Started Aug 2014; status: completed.

02

Drugs

simethicone
03

Conditions

abdominal bloatingflatulence

Beyond the preview

Go deeper on NCT02984176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02984176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call